BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10547289)

  • 1. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
    Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
    Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
    J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidinobenzoic acid inhibitors of influenza virus neuraminidase.
    Sudbeck EA; Jedrzejas MJ; Singh S; Brouillette WJ; Air GM; Laver WG; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Luo M
    J Mol Biol; 1997 Apr; 267(3):584-94. PubMed ID: 9126840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
    Varghese JN; Epa VC; Colman PM
    Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
    J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.
    Maring CJ; Stoll VS; Zhao C; Sun M; Krueger AC; Stewart KD; Madigan DL; Kati WM; Xu Y; Carrick RJ; Montgomery DA; Kempf-Grote A; Marsh KC; Molla A; Steffy KR; Sham HL; Laver WG; Gu YG; Kempf DJ; Kohlbrenner WE
    J Med Chem; 2005 Jun; 48(12):3980-90. PubMed ID: 15943472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ; Du QS; Sun H; Chou KC
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active site modulation in the N-acetylneuraminate lyase sub-family as revealed by the structure of the inhibitor-complexed Haemophilus influenzae enzyme.
    Barbosa JA; Smith BJ; DeGori R; Ooi HC; Marcuccio SM; Campi EM; Jackson WR; Brossmer R; Sommer M; Lawrence MC
    J Mol Biol; 2000 Oct; 303(3):405-21. PubMed ID: 11031117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains.
    Kati WM; Saldivar AS; Mohamadi F; Sham HL; Laver WG; Kohlbrenner WE
    Biochem Biophys Res Commun; 1998 Mar; 244(2):408-13. PubMed ID: 9514938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Air GM; Luo M
    Proteins; 1995 Oct; 23(2):264-77. PubMed ID: 8592707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
    Hitaoka S; Harada M; Yoshida T; Chuman H
    J Chem Inf Model; 2010 Oct; 50(10):1796-805. PubMed ID: 20863103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
    Stoll V; Stewart KD; Maring CJ; Muchmore S; Giranda V; Gu YG; Wang G; Chen Y; Sun M; Zhao C; Kennedy AL; Madigan DL; Xu Y; Saldivar A; Kati W; Laver G; Sowin T; Sham HL; Greer J; Kempf D
    Biochemistry; 2003 Jan; 42(3):718-27. PubMed ID: 12534284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.
    Hart GJ; Bethell RC
    Biochem Mol Biol Int; 1995 Jul; 36(4):695-703. PubMed ID: 8528132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
    White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
    J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.